Oxford Nanopore Technologies (ONT) - Stock & Dividends

Exchange: London Exchange • Country: United Kingdom • Currency: GBX • Type: Common Stock • ISIN: GB00BP6S8Z30

Nanopore Sequencers, DNA/RNA Analysis Tools, Sequencing Devices

Oxford Nanopore Technologies Ltd is a pioneering biotech company that develops and commercializes innovative nanopore-based sequencing platforms. These platforms enable real-time analysis of DNA and RNA, revolutionizing the field of genomics and beyond.

The company operates in two main segments: Life Science Research Tools and Covid Testing. Its product portfolio includes portable, flexible, and high-throughput sequencing devices, such as MinION, GridION, and PromethION, which cater to various research and diagnostic applications.

MinION, a portable device, allows for DNA and RNA analysis in real-time, making it an ideal tool for researchers and scientists in the field. GridION, a benchtop sequencer, offers flexibility and high-throughput capabilities, while MinION Mk 1C provides a self-contained and portable sequencing solution.

Flongle, an adapter for MinION or GridION, enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells. PromethION 2 Solo and PromethION 2 are high-throughput sequencers designed for large-scale research and diagnostic applications.

The company also offers VolTRAX, an automated library prep for nanopore analyses, and Q-Line, a sequencing solution for applied applications. Additionally, Oxford Nanopore Technologies provides products for SAR-CoV-2 testing, contributing to the global effort to combat the pandemic.

Its platform has far-reaching implications, enabling customers to conduct scientific and biomedical research in various areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies was founded in 2005 as Oxford NanoLabs Limited and rebranded in 2008. Headquartered in Oxford, UK, the company continues to push the boundaries of genomic research and diagnostic capabilities.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Oxford Nanopore Technologies (ONT) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Oxford Nanopore Technologies (ONT) - Stock & Dividends

ONT Stock Overview

Market Cap in USD 11m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Biotechnology
TER 0.00%
IPO / Inception

ONT Stock Ratings

Growth 5y -76.2
Fundamental -71.6
Dividend -
Rel. Performance vs Sector -9.04
Analysts -
Fair Price Momentum 60.22 GBX
Fair Price DCF -

ONT Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

ONT Growth Ratios

Growth 12m -56.63%
Growth Correlation 12m -82%
Growth Correlation 3m -46%
CAGR 5y -49.97%
CAGR/Mean DD 5y -0.84
Sharpe Ratio 12m -1.19
Alpha vs SP500 12m -80.59
Beta vs SP500 5y weekly 0.84
ValueRay RSI 29.24
Volatility GJR Garch 1y 51.00%
Price / SMA 50 -11.16%
Price / SMA 200 -41.59%
Current Volume 1667.1k
Average Volume 20d 911.5k

External Links for ONT Stock

Fund Manager Positions
What is the price of ONT stocks?
As of June 22, 2024, the stock is trading at GBX 92.30 with a total of 1,667,101 shares traded.
Over the past week, the price has changed by -5.72%, over one month by -10.13%, over three months by -30.81% and over the past year by -57.85%.
What are the forecast for ONT stock price target?
According to ValueRays Forecast Model, ONT Oxford Nanopore Technologies will be worth about 66.8 in June 2025. The stock is currently trading at 92.30. This means that the stock has a potential downside of -27.63%.
Issuer Forecast Upside
Wallstreet Target Price 196.7 113
Analysts Target Price - -
ValueRay Target Price 66.8 -27.6